Cancer registry data were reviewed from a nationally representative cohort of 301 Maori (indigenous) patients and 329 randomly selected non-Māori patients who were diagnosed with colon cancer between 1996 and 2003. Rates of surgical resection were similar between Māori and non-Māori patients, although Māori patients were less likely to undergo extensive lymph node clearance and were more likely to die during the postoperative period. Māori patients were significantly less likely to receive chemotherapy for stage III disease (relative risk [RR], 0.69) and were more likely to experience a delay of ≥8 weeks before starting chemotherapy (RR, 1.98). Treatment disparities were not explained by differences in tumor characteristics or patient comorbidity.
There is not much more to add to this paper as it is presented here other than to reinforce that firstly it is our whānau who are affected and secondly, as health providers, we must continue to improve access to, and the quality of, cancer care.
Independent commentary by Dr. Matire Hardwood
Dr Matire Harwood (Ngapuhi) has worked in Hauora Māori, primary health and rehabilitation settings as clinician and researcher since graduating from Auckland Medical School in 1994. She also holds positions on a number of boards, committees and advisory groups including the Health Research Council. Matire lives in Auckland with her whānau including partner Haunui and two young children Te Rangiura and Waimarie.
Research Review publications are intended for New Zealand health professionals.
Disclaimer: This publication is not intended as a replacement for regular medical education but to assist in the process. The reviews are a summarised interpretation of the published study and reflect the opinion of the writer rather than those of the research group or scientific journal. It is suggested readers review the full trial data before forming a final conclusion on its merits.
